Company Performance - MaiPu Medical's stock price reached a historical high, increasing by 4.15% to 83.79 yuan, with a trading volume of 407,000 shares and a transaction amount of 33.12 million yuan, resulting in a turnover rate of 0.73% [2] - The latest total market capitalization of the company in A-shares is 5.581 billion yuan, while the circulating market capitalization is 4.698 billion yuan [2] - The company's Q1 report shows a revenue of 73.70 million yuan, representing a year-on-year growth of 28.84%, and a net profit of 24.16 million yuan, with a year-on-year increase of 61.68% [2] Industry Overview - The pharmaceutical and biotechnology industry, to which MaiPu Medical belongs, has an overall increase of 0.29%, with 242 stocks rising, including notable gainers like Sino Medical, Sanxin Medical, and Fuan Pharmaceutical, which rose by 13.82%, 13.50%, and 10.73% respectively [2] - Conversely, 238 stocks in the industry experienced declines, with major losers including Hitec Biology, Peking University Pharmaceutical, and Anglikang, which fell by 8.40%, 6.64%, and 5.41% respectively [2] Financing Data - As of August 11, the latest margin trading balance for MaiPu Medical is 55.33 million yuan, with a financing balance of 55.32 million yuan, reflecting a decrease of 7.13 million yuan over the past 10 days, which is a decline of 11.41% [2]
迈普医学创历史新高,融资客减仓